We are live on ! Find out more
KRON

Kronos Bio
KRON

Delisted

KRON was delisted on the 20th of June, 2025.

Back to rankings

83 hedge funds and large institutions have $812M invested in Kronos Bio in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 7

32% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 19

8% more funds holding

Funds holding: 77 → 83 (+6)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

2.27% less ownership

Funds ownership: 71.11% → 68.84% (-2.3%)

15% less capital invested

Capital invested by funds: $956M → $812M (-$145M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2K

Holders
83
Holders Change
+6
Holders Change %
+7.79%
% of All Funds
1.45%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
25
Reduced
19
Closed
7
Calls
–
Puts
$2K
Net Calls
-$2K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$8.02M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$5.47M
3
Franklin Resources
Franklin Resources
California
+$5.45M
4
Victory Capital Management
Victory Capital Management
Texas
+$3.56M
5
Charles Schwab
Charles Schwab
California
+$2.89M

Top Sellers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
-$40.7M
2
HA
HHLR Advisors
Cayman Islands
-$6.01M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.52M
4
OCA
Octagon Capital Advisors
New York
-$3.5M
5
PA
Perceptive Advisors
New York
-$2.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$7.39M +$576K +26,813 +8%
CC
27
Commodore Capital
New York
$6.26M – – –
Charles Schwab
28
Charles Schwab
California
$5.88M +$2.89M +134,534 +92%
PAMS
29
Pictet Asset Management (Switzerland)
Switzerland
$3.84M +$3.93M +183,099 New
N
30
Nuveen
North Carolina
$3.82M +$437K +20,325 +13%
BP
31
BBR Partners
New York
$3.42M -$11.9K -553 -0.3%
HA
32
HHLR Advisors
Cayman Islands
$3.22M -$6.01M -279,738 -65%
UBS AM
33
UBS AM
Illinois
$2.99M -$74.3K -3,457 -2%
Morgan Stanley
34
Morgan Stanley
New York
$2.84M -$789K -36,733 -21%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$2.84M +$476K +22,179 +20%
Goldman Sachs
36
Goldman Sachs
New York
$2.44M +$1.9M +88,325 +314%
CBA
37
Coastal Bridge Advisors
Connecticut
$1.65M -$773K -36,000 -31%
SB
38
Samsara BioCapital
California
$1.64M – – –
TD Asset Management
39
TD Asset Management
Ontario, Canada
$1.15M – – –
B
40
Bailard
California
$1.11M +$58K +2,700 +5%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$1.09M +$37.4K +1,743 +3%
State of Wisconsin Investment Board
42
State of Wisconsin Investment Board
Wisconsin
$1.05M +$25.6K +1,194 +2%
Ameriprise
43
Ameriprise
Minnesota
$905K +$80.3K +3,737 +9%
AllianceBernstein
44
AllianceBernstein
Tennessee
$824K – – –
CS
45
Credit Suisse
Switzerland
$780K +$616K +28,653 +333%
Swiss National Bank
46
Swiss National Bank
Switzerland
$778K – – –
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$728K -$403K -18,774 -35%
Cerity Partners
48
Cerity Partners
New York
$629K – – –
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$589K -$115K -5,337 -16%
SG Americas Securities
50
SG Americas Securities
New York
$490K +$502K +23,361 New
1
2
3 4

KRON Hedge Fund Activity: Q3 2021 in Review

83 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q3 2021, worth a combined $812M — down 15% from $956M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new KRON positions and 7 closed out — a net gain of 7 holders — while 25 added to existing stakes and 19 trimmed.

The largest buyer was Vanguard Group, adding an estimated $8.02M. The largest seller was Capital Research Global Investors, cutting an estimated $40.7M.

  • 83 institutional investors held Kronos Bio (KRON) as of Q3 2021, up from 77 in Q2 2021.
  • Funds reported $812M of Kronos Bio stock for Q3 2021, down 15% quarter-over-quarter.
  • 14 funds opened new Kronos Bio positions in Q3 2021 and 7 closed out, a net change of +7 holders.
  • The largest Kronos Bio buyer in Q3 2021 was Vanguard Group, an estimated $8.02M added.
  • The largest Kronos Bio seller in Q3 2021 was Capital Research Global Investors, an estimated $40.7M sold.

Based on aggregated 13F filings for Q3 2021.